ATE80295T1 - Fettsaeure und cyclosporin enthaltende zusammensetzung mit ermaessigter nephrotoxizitaet. - Google Patents

Fettsaeure und cyclosporin enthaltende zusammensetzung mit ermaessigter nephrotoxizitaet.

Info

Publication number
ATE80295T1
ATE80295T1 AT87903559T AT87903559T ATE80295T1 AT E80295 T1 ATE80295 T1 AT E80295T1 AT 87903559 T AT87903559 T AT 87903559T AT 87903559 T AT87903559 T AT 87903559T AT E80295 T1 ATE80295 T1 AT E80295T1
Authority
AT
Austria
Prior art keywords
fatty acid
cyclosporine
compositions
acceptable salt
methods
Prior art date
Application number
AT87903559T
Other languages
English (en)
Inventor
Vicki E Kelley
William M Bennett
Original Assignee
Brigham & Womens Hospital
Univ Oregon Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital, Univ Oregon Health Sciences filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of ATE80295T1 publication Critical patent/ATE80295T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87903559T 1986-05-02 1987-05-04 Fettsaeure und cyclosporin enthaltende zusammensetzung mit ermaessigter nephrotoxizitaet. ATE80295T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85900286A 1986-05-02 1986-05-02
PCT/US1987/001024 WO1987006463A1 (en) 1986-05-02 1987-05-04 A composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine
EP87903559A EP0305400B1 (de) 1986-05-02 1987-05-04 Fettsäure und cyclosporin enthaltende zusammensetzung mit ermässigter nephrotoxizität

Publications (1)

Publication Number Publication Date
ATE80295T1 true ATE80295T1 (de) 1992-09-15

Family

ID=25329727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87903559T ATE80295T1 (de) 1986-05-02 1987-05-04 Fettsaeure und cyclosporin enthaltende zusammensetzung mit ermaessigter nephrotoxizitaet.

Country Status (7)

Country Link
EP (1) EP0305400B1 (de)
JP (1) JP2574354B2 (de)
AT (1) ATE80295T1 (de)
AU (1) AU588695B2 (de)
CA (1) CA1302879C (de)
DE (1) DE3781686T2 (de)
WO (1) WO1987006463A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300675A3 (de) * 1987-07-21 1990-04-11 Merck Frosst Canada Inc. Methode zur Verbesserung der Cyclosporintherapie
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
CH679119A5 (de) * 1988-05-13 1991-12-31 Sandoz Ag
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
US5516801A (en) * 1992-08-21 1996-05-14 Scotia Holdings Plc Fatty acid treatment for ectopic calcium deposition
GB9217781D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
SK277092A3 (en) * 1992-09-07 1996-08-07 Galena As Medicaments with n-methylated cyclic undecapeptides
CN1077800C (zh) * 1993-07-01 2002-01-16 韩美药品工业株式会社 环孢菌素软胶囊组合物
JP4761093B2 (ja) * 1997-12-10 2011-08-31 シクロスポリン セラポイティクス リミテッド オメガ−３脂肪酸油を含む医薬組成物
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1819297B1 (de) 2004-09-28 2015-01-14 Atrium Medical Corporation Uv-gehärtetes gel und herstellungsverfahren
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1506563A (en) * 1974-04-25 1978-04-05 Williams J Immunosuppressive agents
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
EP0087865B1 (de) * 1982-03-01 1986-10-01 Efamol Limited Pharmazeutische Zusammensetzung

Also Published As

Publication number Publication date
DE3781686T2 (de) 1993-03-11
JPH01503296A (ja) 1989-11-09
CA1302879C (en) 1992-06-09
EP0305400B1 (de) 1992-09-09
JP2574354B2 (ja) 1997-01-22
EP0305400A1 (de) 1989-03-08
AU7438287A (en) 1987-11-24
WO1987006463A1 (en) 1987-11-05
DE3781686D1 (de) 1992-10-15
EP0305400A4 (de) 1989-11-07
AU588695B2 (en) 1989-09-21

Similar Documents

Publication Publication Date Title
ATE80295T1 (de) Fettsaeure und cyclosporin enthaltende zusammensetzung mit ermaessigter nephrotoxizitaet.
EP0347056B1 (de) Zusammensetzungen essentieller Fettsäuren
IL112664A (en) 4-amino derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
DE3577851D1 (de) Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
WO1997039759A3 (en) Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
IT1223290B (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
IT1176916B (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
EP0364094A2 (de) Verwendung von Fettsäuren zur Behandlung von myalgischer Enzephalomyelitis
BG103335A (en) Application of fumaric acid derivatives
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
ATE333275T1 (de) Indole-3-propionsäure, ihre salze und ester als arzneimittel
DK0502925T3 (da) præparat til behandling af inflammatoriske tarmlidelser
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
SE8303003D0 (sv) Medel for att oka antitumorverkan hos antitumormedel
DE68917678D1 (de) Verfahren und Mittel zur Behandlung der Alzheimer-Krankheit, verwandter Demenzen und Epilepsie.
ATE115585T1 (de) Bilobalid-phospholipid-komplexe, ihre anwendung und zusammensetzungen enthaltend diese.
BE1002504A3 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
ATE110274T1 (de) Mittel zur verbesserung spezifischer eigenschaften des blutes.
DE69430416T2 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
BE900125A (fr) Compositions pharmaceutiques synergiques.